![]()
ISSN 0974-3618
(Print) www.rjptonline.org
0974-360X (Online)
RESEARCH ARTICLE
Separating
and determining the effective compounds percentage in Ecballium elaterium
L. Cucurbitacins Syria
Manal Darwish*, Mohamed Isam Hasan Agha2, Soufi Barkil3,
Oussama Mansour4
1Department of Pharmacognosy, Faculty of Pharmacy, Al-Andalus University for Medical Science,
Al-Qdmous, Syria.
2Department of Pharmacognosy, Faculty of Pharmacy, Damascus University
3Department of Toxicology and Pharmacology-Faculty of Pharmacy-Damascus University
4Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Alndalus University for Medical Science, Al-Qdmous, Syria.
*Corresponding
Author E-mail: mansouroussama@yahoo.fr
ABSTRACT:
The Ecballium elaterium L. which grows in
the Mediterranean region is considered one of the well known plants in folk
medicine in treating liver diseases, especially jaundice.
Recent studies have indicated its
effectiveness in this area in addition to its valid use in the treatment of
Enfluenza, Analgesic and antipyretic and Anti-in flammation. Its fruit is
usually used due to the high percentage of the active ingredients and the ease
of extraction without ruining or damaging these active ingredients. This
extraction contains a set of tri-terpene compounds responsible for the
pharmaceutical effectiveness of the plant. These compounds are called
Cucurbitacins and they have several types. The study aims at conducting a
series of tests and chemical assay in order to determine the juice content of
chemical components and calibrate Cucurbitacins existed in the plant using the available ways (HPLC). The plant fruit
was collected from the coastal region and identified by morphological
characteristics of sex and gender. Afterwards, it was manually squeezed ,
purified, and properly tested to detect and calculate the concentrations of
Cucurbitacins especially Cuc I and Cuc E. HPLC Examination of the intense
methanolic juice, conducted on the waves (230 nm, 254 nm), has confirmed
the presence of Cuc I and Cuc E
(concentration of Cuc E was greater than that of Cuc I ).
KEY WORDS: Ecballium elaterium L., Cucurbitacin (Cuc), HPLC.
INTRODUCTION:
Ecballium elaterium L, which is from the Cucurbitaceae family(1,2,7)
widespread in Syria (the coastal and the southern region)(8), with
its active components of the Cucurbitacins has been considered extremely
affective in curing many diseases(3,4,5). It is widely used in
treating liver diseases particularly (Hepatitis(9)). Moreover, it is
used in the treatment of rheumatism(6) Viral disease(9) ,sinusitis (10) herpes
zoster(11,12).
Received on 29.03.2015
Modified on 08.04.2015
Accepted on 21.04.2015 ©
RJPT All right reserved
Research J. Pharm. and Tech.
8(7): July, 2015; Page 829-835
DOI: 10.5958/0974-360X.2015.00135.3
The plant includes several elements in its
liquid juice, and the intense extract of the ripe fruit consist of proteins,
which range in molecular weight between 13 → 103 KDa, lipids, sugars,
minerals and Cucurbitacins(2) (Figure1) which are classified as a
group of active compounds ( triterpens, tetracyclic) that are different from
each other where a set of hydroxyl is in positions C2, C3, C19 and C24, the
cationic function is in position C3, the double bond is between C1 and C2, and
between C23 and C24, acetalation of the hydroxyl set is in position C26. The
taste of the juice is also bitter, and it contains cucurbitacins B, D, E, I, R,
and L which lots of biological activities are attributed to. Ecballium elaterium L. is a highly toxic plant and not appropriate for internal
use; it causes severe irritation to the digestive tract(2) although
it is used to treat liver toxicity(13). The plant extract,
especially its fruit, is rich in Elatrium which in large doses may cause nausea
and vomiting; moreover, and in case of repeated use, it may cause severe
inflammation in the stomach and in testiness that leads to death(14).
Ocular exposure can cause conjunctivitis and corneal edema erosion. Dermatitis
occurs within minutes of exposure due to the irritation of the mucous membrane
with varying degrees of severity (intensity). Intranasal administration can lead
to irritation of the mucous membranes, and it is manifested in pharyns,
dyspnea, drooling, dysphagia, and upper airway obstruction(15,16).

Figure 1: The general structure of
Cucurbitacins
MATERIALS AND METHODS:
Cucurbitacins I,
Cucurbitacins E were obtained from Genay France company, Acetonitrile ACN,
Methanol MeOH ,Water H2O for
HPLC (Shamlab Company).
·
HPLC type JASCO equipped with the
followings:
·
(PU-980 Intelligent HP, UV-detector pump
970 Intelligent UV / VIS).
·
ColumnC18 (250 mmx4.6mm), (Kromasil).
·
Ultrasonic Model 310 T (Germany).
·
Filters measure 0.45μM (Whatman).
·
Rotavpor model 111 BUCHI RE Labconco.
·
Centrifuge Heraeuslobofuge 200.
·
Stirrer model Snijders 34532.
Preparation of the
Juice:
Ripe fruits were
collected from costal region and squeezed to get the crude fruit, filtered in
order to remove seeds and the remaining tissues, and then they were centrifuged
at 5,000 r / min for 40 minutes. Afterwards, they were filtered twice through
membrane filters with the dimensions of 0.45 μM. Clear juice (500 ml) as
pale watery liquid was obtained, and it was kept in sterile tubes at a
temperature (-20C˚)(2)
Analysis of
Cucurbitacins of the Juice:(2)
The extraction of
the active substances from the fruits was carried by adding the clear juice, obtained from the former stage, to
pure methanol, where 100 ml of the juice was mixed with an equal volume of
methanol (100 ml) for two hours at room temperature and using a magnetic motor
to ensure homogeneous stirring and distribution in methanol in order to extract
the active ingredients(2) properly. It was observed separation of
some white parts of the juice which were fibers and proteins. The
centrifugation of the solution was carried at speed 10,000 r / min for 15
minutes/ ˚4C in special covered tubes. Afterwards, the floating solution
was collected, weighed, and placed in a flask of the rotary evaporator. The
temperature was set on ˚40C, and
the pressure inside the flask (65 ± 2 bar). This pressure was suitable to
vaporize the methanol from the liquid. This lasted for two hours until full
vaporization of the liquid. Eventually, the active substances were obtained and
preserved in sterile tubes at temperature -20 ˚C. It is worth mentioning
that we have kept juice samples from the various stages of the work (pure water
juice, methanolic juice before evaporation).
Preparation of
Standards:
Cuc E: solution was obtained with
concentration of 1 mg / ml (equivalent to 1000 μg / ml). Then, a
standardized series was conducted, and the first standardized solution Cuc E
was obtained with concentration of 0.1 mg / ml equivalent to 100 μg / ml,
and the second standardized solution Cuc E with concentration of 0.01 mg/ml
equivalent to10μg/ml.
Cuc I : was prepared in the same
way and the basic solution was obtained with concentration of 1 mg / ml
equivalent to 1000 μg / ml. The first standardized solution Cuc I was
obtained with concentration of 0.1 mg / ml equivalent to 100 μg / ml and
the second Cuc I with concentration of 0.01 mg / ml equivalent to 10mg / ml.
Solutions have been prepared and placed in a sealed airtight glass tubes with
labels reading each concentration with the standard name, and they were left
untouched and preserved at a temperature of -20 Co until use.
High Performance
Liquid Chromatography (HPLC):
The work has been done on waves length of
(230- 254 nm). A comparison between the two waves length was conducted having
in mind that the main work was done on 230 nm wave after testing the results.
Since Cucurbitacins are polar materials, they carry at least one hydroxyl
group, so C18 non-polar material was
chosen separation within a column that has the dimensions (250 ×
RESULTS AND
DISCUSSION:
Appropriacyof the device at the standard
Cuc I: The device was appropriate through injecting five consecutive samples
from the standard using the wave length 230 nm and a concentration of 10
μg / ml (Figure 2), and the value of the relative standard deviation RSD
was less than 2%

Figure 2: standard
chromatography diagram to Cuc I using HPLC
Appropriacy of the device at the standard
Cuc E: The device was appropriate through injecting five consecutive samples
from the standard using the wave length 230 nm and a concentration of 100
μg / ml, (Figure 3), and the value of the relative standard deviation RSD
was less than 2%

Figure 3: standard
chromatography diagram of Cuc E using HPLC
Calculating the concentration of the plant
intense extract: Comparing the results of the injection of the extended
methanolic extract with standars Cuc I and Cuc E , it is possible the
concentration of the plant extract as the following:
1-Measuring at 230 nm wave length - concentration of Cuc E in the
extended extract = (concentration of standard Cuc E × area of standard Cuc E in
extract) / (area of standard Cuc E) = (100 × 674741.218) /1047715.061 = 64.4
µg/ml Thus, the concentration of Cuc E in intense methanolic extract of plant
is: (Concentration × volume) before extension = (concentration × volume) after
extension Concentration = (64.4 × 1) /0.25=257.6 μg / ml = 0.26mg / ml so
Concentration in the crude juice 100 ml:
Concentration = (0.26 × 3) /100=0.008 mg / ml - concentration of Cuc I in the
extended extract = (concentration of standard Cuc I × area of standard Cuc E in
extract) / (area of standard CucI) = (10 × 660177.860) /302250.596 = 21.8 µg/ml
Thus, the concentration of CucI in intense
methanolic extract of plant is: Concentration = (21.8 × 1) /0.25=87.2 μg /
ml = 0.09 mg / ml so concentration in
the crude juice 100 ml: Concentration = (0.09 × 3) /100=0.003 mg / ml
2- Measuring at 254 nm wave length - concentration of Cuc E in the
extended extract = (concentration of standard Cuc E × area of standard Cuc E in
extract) / (area of standard Cuc E) = 62.14 µg/ml - concentration of Cuc I in
the extended extract = (concentration of standard Cuc I × area of standard Cuc
E in extract) / (area of standard Cuc I)21.03= µg/ml All the previous calculations can be summarized in table
(1): Table (1): areas and concentrations of mixed standards together and their
concentrations in extract when use wave lengths
230 nm, 254 nm
|
Peak Area |
Concentration µg/ml |
Sample |
||
|
230 nm Wave Length |
254 nm Wave Length |
230 nm Wave Length |
254 nm Wave Length |
|
|
543201.504 |
460949.554 |
10.00 |
10.00 |
Cuc I Standard |
|
2510867.410 |
2345239.584 |
100.00 |
100.00 |
CucE Standard |
|
302250.596 |
252338.376 |
10.00 |
10.00 |
Cuc I Mixed Standard (CucI+Cuc E) |
|
1047715.061 |
876887.589 |
100.00 |
100.00 |
CucE Mixed Standard (CucI+Cuc E) |
|
660177.860 |
530669.373 |
21.80 |
21.03 |
Cuc I Extract |
|
674741.218 |
544918.975 |
64.40 |
62.14 |
CucE Extract |

Figure 4: chromatography diagram
of standards mixed on 230 nm wave length

Figure 5: chromatography diagram of extract mixed
on 230 nm wave length

Figure 6: chromatography diagram of standards mixed on 254 nm wave lenght

Figure
7: chromatography diagram of extract
mixed on 254 nm wave length
Internal standard injection:
After
mixing standards Cuc E and Cuc I with the extract ; it was injected. comparing areas and the resulting concentrations with their
parallels from the extract, the concentrations were calculated as follows: -
concentration of Cuc I compound (extract)= (concentration of Cuc I standard ×
area of Cuc I extract) / (area of Cuc I standard) = 10 × 703416.108
/ 329366.031 = 21.3566 μg / ml - concentration of
Cuc I compound (extract+ standard) = (concentration of Cuc I standard × area of Cuc I (extract+
standard)) / (area of Cuc I standard) = 10 × 1031843.718 /
329366.031
= 31.3281
μg / ml - concentration of Cuc E compound (extract) = (concentration of
Cuc E standard × area of Cuc E extract) / (area of Cuc I standard) = (100 ×
577260.7) /1532809.0481
= 37.66μg / ml - concentration of CucE compound (extract+ standard) =
(concentration of CucE standard × area of CucE (extract+ standard)) / (area of
CucE standard) = (100 × 2084620.305) /1532809.0481 = 137μg /
ml
Figures
(10,8.9) and Table (2) show that the increase in peaks areas and concentrations
belonging to the two compounds Cuc I and Cuc E in the mixture (extract +
standards) equals peaks areas and concentrations belonging to the standards,
which confirms the presence of the two compounds Cuc I and Cuc E in the studied
extract. and the area of the peaks and concentrations that was calculated
belong to them:
Table 2 : concentrations and areas of Cuc I, Cuc E in the standards ,
extract, and the internal standard
|
Cuc I Standard |
Cuc I Extract |
Cuc I Extract)+Standard) |
Cuc E Standard |
Cuc E Extract |
Cuc E Extract)+(Standard |
Samples |
|
329366.031 |
703416.108 |
1031843.718 |
1532809.048 |
577260.700 |
2084620.305 |
Peak Area |
|
10.0000 |
21.3566 |
31.3281 |
100.0000 |
37.6600 |
137.0000 |
Concentration µg/ml |

Figure 8 : chromatography diagram
to standards mixture

Figure 9: chromatography diagram for
extract mixture

Figure 10 : chromatography diagram for internal standard mixture)
CONCLUSION:
The
extract content of active substances in this study has been determined by
conducting a series of particular chemical tests. Cucurbitacins, particularly
compounds Cuc I and Cuc E in juice, has been detected, and their concentrations
calculated. The fact that Cucurbitacinsis are responsible for the biological
activity of the plant, their existence have been confirmed by the high performance
liquid chromatography (HPLC) examination, which was conducted on the wave
length (230 nm, 254 nm) to the intense methanolic extract. Concentration of Cuc
E compound is greater than the concentration of Cuc I compound. This result matches international studies and
research(2). There is no statistical difference in the
concentrations values on the two waves lengths; however, the absorption is
bigger and better on the wavelength (230 nm).
ACKNOWLEDGEMENT:
I would
like to thank Mr. Ayham Aljghami, Instructor
at The Higher Institute of Languages-Tishreen University-Syria, for the
language assistance provided during the writing process of this article.
REFERENCES:
1- Youssef
A, Mansour O, A Histological – Chemical
Comparative Study of Two Species of Inula (I. Viscosa and I. Graveolens)
Distributed in The Syrian Coast, Tishreen
University Journal for Research and Scientific Studies – Health Sciences Series,
35, 1; 2013:71- 92.
2-
H´el`ene Greige, et al. Cucurbitacins from Ecballium elaterium
juice increase the binding of bilirubin
and ibuprofen to albumin in human plasma , the journal of Elsevier, 169;
2007:53-62.
3-
Essam M.A, et al. Evaporate of Ecbalium elaterium fruit
extract for treating viral symptoms, the
journal of United States Patent,
20 ; 2007: 13-16.
4-
Khatib S. Y, et al. Effects of crude Ecballium elaterium juice on isolated
rabbit heart, International journal of
pharmacology, 31; 1993: 259 -260-261.
5-
Fathi T.
Halaweish, et al. Method of using cucurbitacins compounds , the journal of United States Patent,
March, 1; 2007: 7-12.
6-
AgilAM,
et al. Analgesic and Antipyretic Effects of Ecballium
elaterium (L.) A. Richard. Extract in
Rodents , the journal of Phytotherapy Research. 9; 1995:
135-139.
7-
George E et al. Flora of Syria, Plasetine, and Sinai From
The Tourus to Ramuhummed and From Mediteranean Sea To The Syrian Desert, The
American press Beirut , Syria ,pp. 322-324.
8-
Finley
Ellingwood M.D .The American Materia Medica, Therapeutics and Pharmacognosy, 1919.
9-
Essam MA
, et al. Herbal compositions and treatment methods , the journal of United States Patent., vol.22 ; 2004:1-4.
10-
Elias E. Mazokopakis, et al. The Safety
and Efficacy of the Fruit Juice of Ecballium elaterium in the
Treatment of Acute Rhinosinusitis, the journal of Alternative and Complementary.
vol. 15; 2009: 1273-1274.
11-
Essam
MA, et al. .Evaporate of Ecbalium elaterium
fruit extract for treating viral symptoms, the journal of United States
Patent. 20; 2007: 13-16.
12-
Essam MA
, et al. Herbal compositions and treatment methods , the journal of United States Patent. 22; 2004: 1- 4.
13- Agil A, et al . Isolation of an anti-hepatoxic principle
from the juice of Ecballium elaterium,
the journal of Planta Med. 65; 1999: 673-675 .
14-
Salhab A
S., et al .The Acute Toxicity of the Juice of Ecballium Elatrium (L.) A. Rich, the journal of Crude Drug Res.13; 11.1986.
15-
Raikhlin-Eisenkraft
B, et al .Ecbalium elaterium (squirting cucumber)-remedy or
poison?, the journal of Clinical Toxicology.38;
2000: 305-308.
16-
Eray O,
et al. Severe uvular angioedema caused by intranasal administration of Ecbalium elaterium, the journal
of Vet Hum Toxicol.41;1999:
376-377.